Cargando…
Characteristics of US Blood Donors Testing Reactive for Antibodies to SARS-CoV-2 Prior to the Availability of Authorized Vaccines
In the United States, many blood collection organizations initiated programs to test all blood donors for antibodies to SARS-CoV-2, as a measure to increase donations and to assist in the identification of potential donors of COVID-19 convalescent plasma (CCP). As a result, it was possible to invest...
Autores principales: | Dodd, Roger Y, Spencer, Bryan R, Xu, Meng, Foster, Gregory A, Saá, Paula, Brodsky, Jaye P, Stramer, Susan L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8321690/ https://www.ncbi.nlm.nih.gov/pubmed/34373145 http://dx.doi.org/10.1016/j.tmrv.2021.07.001 |
Ejemplares similares
-
A Longitudinal Study of Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Response in a Subset of United States Blood Donors
por: Tonnetti, Laura, et al.
Publicado: (2022) -
Risk factors and epidemiology of human T-lymphotropic virus types 1 and 2 in US blood donors
por: Vahidnia, Farnaz, et al.
Publicado: (2015) -
Trajectory and Demographic Correlates of Antibodies to SARS-CoV-2 Nucleocapsid in Recently Infected Blood Donors, United States
por: Haynes, James M., et al.
Publicado: (2023) -
Use of US Blood Donors for National Serosurveillance of Severe Acute Respiratory Syndrome Coronavirus 2 Antibodies: Basis for an Expanded National Donor Serosurveillance Program
por: Stone, Mars, et al.
Publicado: (2021) -
Genetic Variability of West Nile Virus in U.S. Blood Donors from the 2012 Epidemic Season
por: Grinev, Andriyan, et al.
Publicado: (2016)